Literature DB >> 19138155

Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection.

Hoang Truong Long1, Martin L Hibberd2, Tran Tinh Hien3, Nguyen Minh Dung3, Tran Van Ngoc3, Jeremy Farrar1,4, Bridget Wills1,4, Cameron P Simmons1,4.   

Abstract

DNA microarrays and specific reverse-transcription polymerase chain reaction assays were used to reveal transcriptional patterns in the blood of children presenting with dengue shock syndrome (DSS) and well-matched patients with uncomplicated dengue. The transcriptome of patients with acute uncomplicated dengue was characterized by a metabolically demanding "host-defense" profile; transcripts related to oxidative metabolism, interferon signaling, protein ubiquination, apoptosis, and cytokines were prominent. In contrast, the transcriptome of patients with DSS was surprisingly benign, particularly with regard to transcripts derived from apoptotic and type I interferon pathways. These data highlight significant heterogeneity in the type or timing of host transcriptional immune responses precipitated by dengue virus infection independent of the duration of illness. In particular, they suggest that, if transcriptional events in the blood compartment contribute to capillary leakage leading to hypovolemic shock, they occur before cardiovascular decompensation, a finding that has implications for rational adjuvant therapy in this syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138155      PMCID: PMC4333209          DOI: 10.1086/596507

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?

Authors:  H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

4.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

5.  Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

Authors:  M S Diamond; T G Roberts; D Edgil; B Lu; J Ernst; E Harris
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 6.  Corticosteroids for treating dengue shock syndrome.

Authors:  R Panpanich; P Sornchai; K Kanjanaratanakorn
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

7.  Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression.

Authors:  Meleri Jones; Andrew Davidson; Linda Hibbert; Petra Gruenwald; Joerg Schlaak; Simon Ball; Graham R Foster; Michael Jacobs
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2.

Authors:  M Juffrie; G M Meer; C E Hack; K Haasnoot; A J Veerman; L G Thijs
Journal:  Am J Trop Med Hyg       Date:  2001-07       Impact factor: 2.345

9.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; T P Endy; B Raengsakulrach; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

10.  Host gene expression profiling of dengue virus infection in cell lines and patients.

Authors:  Joshua Fink; Feng Gu; Ling Ling; Thomas Tolfvenstam; Farzad Olfat; Keh Chuang Chin; Pauline Aw; Joshy George; Vladimir A Kuznetsov; Mark Schreiber; Subhash G Vasudevan; Martin L Hibberd
Journal:  PLoS Negl Trop Dis       Date:  2007-11-21
View more
  43 in total

Review 1.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

Review 2.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? Questions Raised by the Development and Implementation of Dengue Vaccines: Example of the Sanofi Pasteur Tetravalent Dengue Vaccine.

Authors:  Bruno Guy
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 3.  Transcriptomic immune profiles of human flavivirus-specific T-cell responses.

Authors:  Alba Grifoni; Yuan Tian; Alessandro Sette; Daniela Weiskopf
Journal:  Immunology       Date:  2020-01-07       Impact factor: 7.397

Review 4.  The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications.

Authors:  Michael J Carter; Ruth M Mitchell; Patrick M Meyer Sauteur; Dominic F Kelly; Johannes Trück
Journal:  Front Immunol       Date:  2017-06-01       Impact factor: 7.561

5.  Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation.

Authors:  Marcin Kwissa; Helder I Nakaya; Nattawat Onlamoon; Jens Wrammert; Francois Villinger; Guey Chuen Perng; Sutee Yoksan; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Rafi Ahmed; Bali Pulendran
Journal:  Cell Host Microbe       Date:  2014-06-26       Impact factor: 21.023

Review 6.  Innate immunity to dengue virus infection and subversion of antiviral responses.

Authors:  Angela M Green; P Robert Beatty; Alexandros Hadjilaou; Eva Harris
Journal:  J Mol Biol       Date:  2013-12-03       Impact factor: 5.469

Review 7.  Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains.

Authors:  Claire Balas; Audrey Kennel; Florence Deauvieau; Regis Sodoyer; Nadege Arnaud-Barbe; Jean Lang; Bruno Guy
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

8.  Gene expression profiling to predict viridans group streptococcal and invasive fungal infection in pediatric acute myeloid leukemia: a brief report from the Children's Oncology Group.

Authors:  Grace E Lee; Lillian Sung; Brian T Fisher; Kathleen E Sullivan; Tom McWilliams; John W Tobias; Soheil Meshinchi; Todd A Alonzo; Alan Gamis; Richard Aplenc
Journal:  Acta Haematol       Date:  2013-11-06       Impact factor: 2.195

9.  Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.

Authors:  Margalida Rotger; Kristen K Dang; Jacques Fellay; Erin L Heinzen; Sheng Feng; Patrick Descombes; Kevin V Shianna; Dongliang Ge; Huldrych F Günthard; David B Goldstein; Amalio Telenti
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

10.  Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism.

Authors:  P'ng Loke; Samantha N Hammond; Jacqueline M Leung; Charles C Kim; Sajeev Batra; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.